Musto P - Search Results

1

Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial.

Cavallaro G, Grassi A, Pavoni C, Micò MC, Busca A, Cavattoni IM, Santarone S, Borghero C, Olivieri A, Milone G, Chiusolo P, Musto P, Saccardi R, Patriarca F, Pane F, Saporiti G, Rivela P, Terruzzi E, Cerretti R, Marotta G, Carella AM, Nagler A, Russo D, Corradini P, Bernasconi P, Iori AP, Castagna L, Mordini N, Oldani E, Di Grazia C, Bacigalupo A, Rambaldi A. Cavallaro G, et al. Among authors: musto p. Blood Cancer J. 2024 Aug 21;14(1):141. doi: 10.1038/s41408-024-01116-5. Blood Cancer J. 2024. PMID: 39168989 Free PMC article. Clinical Trial.

2

Flow cytometric characterization of CD34+ hematopoietic progenitor cells in mobilized peripheral blood and bone marrow of cancer patients.

D'Arena G, Cascavilla N, Musto P, Greco M, Di Mauro L, Carella AM, Dello Iacono N, Carotenuto M. D'Arena G, et al. Among authors: musto p. Haematologica. 1996 May-Jun;81(3):216-23. Haematologica. 1996. PMID: 8767526

3

Are "early" and "late" T-acute lymphoblastic leukemias different diseases? A single center study of 34 patients.

Cascavilla N, Musto P, D'Arena G, Ladogana S, Melillo L, Carella AM, Perla G, Matera R, Carotenuto M. Cascavilla N, et al. Among authors: musto p. Leuk Lymphoma. 1996 May;21(5-6):437-42. doi: 10.3109/10428199609093441. Leuk Lymphoma. 1996. PMID: 9172808

4

CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.

Cascavilla N, Musto P, D'Arena G, Melillo L, Carella AM, Petrilli MP, Sanpaolo G, Carotenuto M. Cascavilla N, et al. Among authors: musto p. Haematologica. 1998 May;83(5):392-7. Haematologica. 1998. PMID: 9658721 Clinical Trial.

5

Thalidomide abolishes transfusion-dependence in selected patients with myelodysplastic syndromes.

Musto P, Falcone A, Sanpaolo G, Bisceglia M, Matera R, Carella AM. Musto P, et al. Haematologica. 2002 Aug;87(8):884-6. Haematologica. 2002. PMID: 12161367 No abstract available.

6

Is the scoring system an effective clinico-biological tool in myeloid antigen positive adult acute lymphoblastic leukemia? Results of a long-term study.

Cascavilla N, Musto P, Melillo L, Bodenizza C, Dell'Olio M, Nobile M, Minervini MM, Perla G, D'Arena G, Carella AM. Cascavilla N, et al. Among authors: musto p. Hematol J. 2002;3(5):251-8. doi: 10.1038/sj.thj.6200186. Hematol J. 2002. PMID: 12391543

7

Efficacy of a single, weekly dose of recombinant erythropoietin in myelodysplastic syndromes.

Musto P, Falcone A, Sanpaolo G, Bodenizza C, La Sala A, Perla G, Carella AM. Musto P, et al. Br J Haematol. 2003 Jul;122(2):269-71. doi: 10.1046/j.1365-2141.2003.04435.x. Br J Haematol. 2003. PMID: 12846896 Free article. Clinical Trial.

8

Pamidronate reduces skeletal events but does not improve progression-free survival in early-stage untreated myeloma: results of a randomized trial.

Musto P, Falcone A, Sanpaolo G, Bodenizza C, Cascavilla N, Melillo L, Scalzulli PR, Dell'Olio M, La Sala A, Mantuano S, Nobile M, Carella AM. Musto P, et al. Leuk Lymphoma. 2003 Sep;44(9):1545-8. doi: 10.3109/10428190309178778. Leuk Lymphoma. 2003. PMID: 14565658 Clinical Trial.

9

Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial.

Palumbo A, Bringhen S, Petrucci MT, Musto P, Rossini F, Nunzi M, Lauta VM, Bergonzi C, Barbui A, Caravita T, Capaldi A, Pregno P, Guglielmelli T, Grasso M, Callea V, Bertola A, Cavallo F, Falco P, Rus C, Massaia M, Mandelli F, Carella AM, Pogliani E, Liberati AM, Dammacco F, Ciccone G, Boccadoro M. Palumbo A, et al. Among authors: musto p. Blood. 2004 Nov 15;104(10):3052-7. doi: 10.1182/blood-2004-02-0408. Epub 2004 Jul 20. Blood. 2004. PMID: 15265788 Free article. Clinical Trial.

10

A reduced intensity conditioning regimen for allografting following autografting is feasible and has strong anti-myeloma activity.

Carella AM, Beltrami G, Corsetti MT, Scalzulli P, Carella AM Jr, Musto P. Carella AM, et al. Among authors: musto p. Haematologica. 2004 Dec;89(12):1534-6. Haematologica. 2004. PMID: 15590410 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

645 results

Search Page

Filters